Oral Semaglutide at a Dose of 25 mg in Adults with Overweight or Obesity
New England Journal of Medicine · 18.09.2025 · 393 (11) · 1077-1087
DOI: 10.1056/nejmoa2500969 ↗Kurz gefasst
Klinische Studie (Phase II) in der Zeitschrift New England Journal of Medicine, erschienen am 18.09.2025. Verfasst von Sean Wharton und 9 weiteren Autor:innen. Beteiligte Einrichtung: University of Toronto, Toronto. Hauptthemen laut MEDLINE: Anti-Obesity Agents, Obesity, Overweight, Weight Loss. Die Arbeit wurde bisher 154-mal zitiert (Crossref) und nennt 16 Literaturangaben. Gefördert von: Novo Nordisk A/S.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- University of Toronto, Toronto.
- York University, Toronto.
- McMaster University, Hamilton, ON, Canada.
- Wharton Weight Management Clinic, Burlington, ON, Canada.
- Department of Internal Medicine and Endocrinology, University of Texas Southwestern Medical Center, Dallas.
- Peter O' Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas.
ORCID-Profile: Ildiko Lingvay
Förderung
- Novo Nordisk A/S
Zitieren
APA
Wharton, S., Lingvay, I., Bogdanski, P., Duque do Vale, R., Jacob, S., Karlsson, T., Shaji, C., Rubino, D., Garvey, W. T., & OASIS 4 Study Group (2025). Oral Semaglutide at a Dose of 25 mg in Adults with Overweight or Obesity. New England Journal of Medicine, 393(11), 1077-1087. https://doi.org/10.1056/nejmoa2500969
Vancouver
Wharton S, Lingvay I, Bogdanski P, Duque do Vale R, Jacob S, Karlsson T, et al. Oral Semaglutide at a Dose of 25 mg in Adults with Overweight or Obesity. New England Journal of Medicine. 2025;393(11):1077-1087. doi:10.1056/nejmoa2500969
BibTeX
@article{Wharton2025,
author = {Wharton, Sean and Lingvay, Ildiko and Bogdanski, Pawel and Duque do Vale, Ruben and Jacob, Stephan and Karlsson, Tobias and Shaji, Chaithra and Rubino, Domenica and Garvey, W Timothy and OASIS 4 Study Group, OASIS 4 Study Group},
title = {Oral Semaglutide at a Dose of 25 mg in Adults with Overweight or Obesity},
journal = {New England Journal of Medicine},
year = {2025},
volume = {393},
number = {11},
pages = {1077--1087},
doi = {10.1056/nejmoa2500969}
}
EUVIMED